A Prospective, Multi-Center Registry to assess Everolimus-Eluting Coronary Stent System (PROMUS Element) for Coronary Revascularization in an Indian Population of Unrestricted Patients - None.

Trial Profile

A Prospective, Multi-Center Registry to assess Everolimus-Eluting Coronary Stent System (PROMUS Element) for Coronary Revascularization in an Indian Population of Unrestricted Patients - None.

Completed
Phase of Trial: Phase IV

Latest Information Update: 29 Aug 2016

At a glance

  • Drugs Everolimus (Primary)
  • Indications Cardiovascular disorders; Coronary artery disease; Coronary artery restenosis
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 25 Sep 2013 Status changed from recruiting to completed as reported by Clinical Trials Registry - India.
    • 08 Aug 2012 New trial record
    • 18 Jul 2012 Status changed from not yet recruiting to recruiting as reported by Clinical Trials Registry - India.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top